Bicycle Therapeutics (BCYC) Gains from Investment Securities (2018 - 2026)

Bicycle Therapeutics has reported Gains from Investment Securities for 9 years, with the latest figure at $66000.0 in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities fell 99.11% year-over-year to $66000.0; the trailing twelve-month figure through Mar 2026 stood at $13.4 million (up 79.21% YoY), and the FY2025 full-year result was $9.8 million, up 12.05% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at $66000.0, down from $13.3 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $13.3 million in Q4 2025, with the low at -$2.1 million in Q4 2022.
• Historically, Gains from Investment Securities has averaged $3.1 million across 5 years, with a median of $2.0 million in 2024.
• Annual changes were most pronounced in 2022 — Gains from Investment Securities sank 14671.43% — and 2025, when it jumped 1555.54%.
• Bicycle Therapeutics' Gains from Investment Securities stood at -$2.1 million in 2022, then soared by 256.38% to $3.2 million in 2023, then plunged by 80.97% to $615496.0 in 2024, then surged by 2058.91% to $13.3 million in 2025, then slumped by 99.5% to $66000.0 in 2026.
• The last three Gains from Investment Securities figures came in at $66000.0 (Q1 2026), $13.3 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.